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Abstract.  The cell adhesion protein t~-agglutinin  is 
bound to the outer surface of the Saccharomyces 
cerevisiae  cell wall and mediates cell-cell contact in 
mating,  a-Agglutinin  is modified by addition of a 
glycosyl phosphatidylinositol  (GPI) anchor as it 
traverses the secretory pathway.  The presence of a GPI 
anchor is essential for cross-linking into the wall, but 
the fatty acid and inositol components of the anchor 
are lost before cell wall association (Lu, C.-E,  J. Kur- 
jan,  and P. N.  Lipke,  1994.  A pathway for cell wall 
anchorage of Saccharomyces cerevisiae  a-agglutinin. 
Mol.  Cell.  Biol.  14:4825-4833.).  Cell wall association 
of ot-agglutinin  was accompanied by an increase in 
size and a gain in reactivity to antibodies directed 
against ~l,6-glucan.  Several kre mutants,  which have 
defects in synthesis of cell wall/~l,6-glucan,  had re- 
duced molecular size of cell wall ot-agglutinin.  These 
findings  demonstrate that the cell wall form of 
oz-agglutinin  is covalently associated with/31,6-glucan. 
The ot-agglutinin  biosynthetic precursors did not react 
with antibody to/~l,6-glucan,  and the sizes of these 
forms were unaffected in kre mutants.  A  COOH- 
terminal truncated form of a-agglutinin,  which is not 
GPI anchored and is secreted into the medium, did 
not react with the anti-/31,6-glucan.  We propose that 
extracellular cross-linkage to/31,6-glucan mediates 
covalent association of a-agglutinin  with the cell wall 
in a manner that is dependent on prior addition of a 
GPI anchor to ot-agglutinin. 
T 
HE cell wall of Saccharomyces cerevisiae consists  of 
two major components:/3 glucans and mannoproteins 
(Ballou,  1982; Cabib et al.,  1982; Fleet,  1991; Klis, 
1994).  The glucan  is composed of two classes:  the/31,3- 
glucan and B1,6-glucan. The/31,3-glucan  consists mainly of 
linear B1,3-1inked glucan with some branching through B1,6 
linkage. This class of glucan has an average of 1,500 glucose 
residues per molecule and forms insoluble fibers (Manners 
et  ai.,  1973a).  The  /~l,6-glucan  contains  predominantly 
B1,6-1inkages with some/31,3-1inked branch points,  and has 
a  degree of polymerization of approximately  140 glucose 
residues (Boone et al.,  1990; Manners  et al.,  1973b).  The 
/31,3-glucan and  the /31,6-glucan are cross-linked  to each 
other,  and association  of Bl,6-glucan  with chitin  has been 
suggested  (Mol and  Wessels,  1987; Surarit  et al.,  1988). 
Several genes involved in cell wall B1,6-glucan biosynthesis 
have been isolated through mutations that confer resistance to 
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the K1  killer toxin,  which binds  to cell wall /31,6-glucan 
(Me,  aden et al., 1990; Boone et al., 1990; Roemer and Bus- 
sey, 1991; Hill et al., 1992; Brown and Bussey, 1993; Brown 
et al., 1993). krel, kre9, and kre11 mutations reduce the level 
of alkali-insoluble  cell wall/31,6-glucan to 60, 20, and 50%, 
respectively  (Boone et al.,  1990; Brown and Bussey, 1993; 
Brown  et al.,  1993).  Smaller  sizes  of the cell wall /~l,6- 
glucan polymer are also found in these mutants.  A kre6 dis- 
ruption  results  in reduced levels of both/~l,3-glucan  and 
/31,6-glucan in the cell wall, but does not affect the size of 
~l,6-glucan (Roemer and Bussey, 1991; Roemer et al., 1993, 
1994). Disruption  of KRE5 reduces/~l,6-glucan content to 
near zero and compromises growth ability (Meaden et al., 
1990). 
The  wall  mannoproteins  are usually of high  molecular 
weight, carrying large amounts of N- and/or O-linked man- 
nosepolysaeeharides (Ballou,  1982, 1988; Fleet, 1991). The 
basis of cell wall association of mannoproteins  are not well 
understood. Some mannoproteins  can be extracted from the 
cell  wall by SDS whereas others are extracted only after 
digestion  of the cell wall with  3-glucanase (Pastor et al., 
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al., 1992). The SDS-extractable mannoproteins appear to be 
non-covalently associated with the cell wall. 5-Glucanase ex- 
tractable mannoproteins have been shown to contain glucose 
residues, and it has been proposed that this class of man- 
noproteins is cross-linked to the wall #-glucan (Shibata et 
al.,  1983;  Pastor et al.,  1984;  Van Rinsum et al.,  1991). 
Some wall mannoproteins have covalently associated #l,6- 
glucan (Montijn et al.,  1994). 
a-Agglutinin is a cell surface marmoprotein expressed by 
ot cells. It binds to a-agglutinin expressed on the surface of 
a ceils to mediate direct cell-cell contact during the mating 
process (Cross et al., 1988; Terrance and Lipke, 1981; Lipke 
and Kurjan, 1992). Mature ot-agglutinin is cell wall anchored 
and can only be extracted by #-glucanase treatment (Lasky 
and Ballou, 1988;  Hauser and Tanner,  1989;  Schreuder et 
al., 1993; Lu et al., 1994).  We have previously shown that 
the ot-agglutinin is synthesized with a glycosyl phosphatidyl- 
inositol (GPI) ~ anchor (Wojciechowicz  et al.,  1993).  GPI- 
linked biosynthetic precursors have been identified, includ- 
ing a  140-kD  ER form and a >300-kD plasma membrane 
form (Wojciechowicz et al., 1993; Lu et al., 1994). A solu- 
ble >300-kD form, which has characteristics of a periplas- 
mic intermediate between the >300-kD plasma membrane 
form and the cell wall form, has also been detected (Lu et 
al., 1994).  A model for GPI anchor-mediated cell wall in- 
tegration of ot-agglutinin  has been proposed based on the 
structure of GPI anchors. Release from the GPI anchor would 
produce  a  periplasmic  intermediate  which  subsequently 
would be linked to the cell wall glucan via a transglycosyla- 
tion reaction (De Nobel and Lipke, 1994; Lu et al., 1994). 
To explore the mechanism of the cell wall anchorage of 
c~-agglutinin, we tested whether this protein is cross-linked 
to the cell wall #-glucan. We show that the (31,3-glucanase- 
extractable cell wall form of ot-agglutinin is covalently linked 
to/~l,6-glucan, but the biosynthetic intermediates are not as- 
sociated with glucan. The implications of these results for 
the mechanism of mannoprotein linkage to the cell wall are 
discussed. 
Materials and Methods 
Yeast Strains and Plasmids 
S.  cerevisiae strain W303-1B  (MATer ade2-1 card-lO0 ura3-1 1eu2-3,112 
trpl-I his3-11,15) was used to express plasmid pAGt~K which contains the 
full  length c~-agglutinin  gena AGod  in YEp352  (Wojciechowicz et al., 
1993). Plasmid pAGoda21'  was constructed by subcloning the 4.5-kb HindIII- 
XbaI fragment from plasmid pAGed621* (Wojciechowicz et al., 1993) into 
YEp352. The agod::LEU2 strain is isogenic to W303-1B and was previously 
described (Lipke et al.,  1989).  LB2134-2B (MATot mnn9 SUC2 real reel 
gal2  CUP1) was obtained from Yeast Genetics Stock Center.  X2180-1A 
(MATc~ SUC2 real mel gal2 CUP1) was used as the tester a strain in the ag- 
glutination  assay.  The  KRE  disruption  mutants  krel::HlS3  (MATcO, 
kre6::HIS3  (MATcO, krell::URA3  (MATe0,  and their isogenic wild type 
strain SEY6210  (MATc~ 1eu2-3,112 ura3-52 his3 lys2 trpl  suc2) were de- 
scribed previously (Boone et al., 1990;  Roemer and Bussey, 1991; Brown 
et al., 1993).  The kre::HlS3 and kre9::HlS3 strains (MATt~) were obtained 
by random sporulation of  a KRES/kre5::HIS3 and KRE9/kre9::HIS3 hetero- 
zygous diploids, respectively, in the SEY6210  background (Spencer and 
Spencer, 1988). 
-1. Abbreviations used in this paper:  endo H, endo-N-acetylglucosamini- 
dase; GPI, glycosyl phosphatidylinositol. 
Metabolic Labeling of Cells 
Labeling with  [35S]methionine  was performed as described (Lu  et al., 
1994). Briefly, exponentially growing cells were collected and resuspended 
at a density of 7  ×  107 cells per ml in sulfate-free medium. TRAN35S - 
LABEL (ICN Biochemieals, Irvine, CA) was added to 20 t~Ci/ml, and the 
suspension was incubated for 30 min at 300C. Synthetic a-factor (a gift of 
Dr. Fred Nalder, College of Staten Island, Staten Island, NY) was added 
to 50 ng/ml cell suspension 10 rain before labeling. At the end of  the labeling 
the cells were collected and washed as described (Lu et al.,  1994).  The 
medium was processed as described below. 
Isolation of Cell Walls and Laminarinase Treatment 
Labeled or unlabeled cells were broken with glass beads in 2% SDS lysis 
buffer containing 50 mM Tris-HC1,  pH 7.4,  150 mM NaCl, 5 mM EIXI'A, 
1 mM PMSF, 30 ~g/ml each of leupeptin, pepstatin, and antipain, followed 
by heating at 100°C for 5 rain. The insoluble cell walls were separated from 
the SDS extract by spinning at 13,600 g for 5 rain, and extracted once with 
SDS lysis buffer by heating for 5 rain at  100°C. The cell wall pellet was 
then washed, and treated with laminarinase as described (Lu et al., 1994). 
Isolation of Secreted ~-Agglutinin from the 
Growth Medium 
ago.l::LEU2[pAGu1621'l  cells were grown in  300  ml  synthetic medium 
without leucine and uracil at 30"C to stationary phase. The growth medium 
was separated from the cells and freeze-dried. The dried material was redis- 
solved in 5 ml of 10 mM Tris-HCl, pH 7.4, and dialyzed against 4 liters 
of 10 mM Tris-HC1,  pH 7.4,  1 mM EDTA, and 0.1 mM PMSF overnight 
at 4°C. For isolating secreted c~-agglutinin from the kre mutants, labeled 
growth media (8 nal) were dialyzed in the above buffer, and the dialysates 
were concentrated  to 1.6 ml. o~Agglutinln was immunoprecipitated from the 
concentrated, dialyzed media. 
Purification of  Anti-fJl,6-Glucan Antibodies 
The anti-/~l,6-glucan antiserum was raised against bovine serum albumin- 
/~l,6-glucan  conjugates in rabbit (Montijn et al.,  1994)  and was purified 
using affinity  chromatography. Epoxy-activated Sepharose 6B (Pharmacia 
Fine Chemicals, Piscataway,  NJ) was used to couple B1,6-glucan via direct 
coupling of free oxirane groups to the hydroxyl groups of the sugars. 360 
nag of pustulan (/31,6-glucan) was dissolved in 21 ml of distilled water by 
autoclaving for 40 rain at 110*C, and incubated with swollen Sepharose gel 
(from 3 mg dried beads) at 37"C for 20 h with shaking. After the coupling, 
excess fll,6-glucan was removed, and the gel was used to pack the column. 
The antiserum was treated with ammonium sulfate to separate albumins 
from the immunoglobulins (Harlow and lane, 1988).  The precipitate was 
redissolved in PBS (Harlow and Lane, 1988),  and applied on the column 
with a flow rate of 0.5 ml/min. The column was washed with at least 10-bed 
volumes of PBS. The bound antibodies were eluted with 0.1 M glycine, pH 
2.5, and dialyzed against distilled water. The purified antibody solution was 
concentrated and stored at  -20"C. 
Immunoprecipitation 
c~-Agglutinin was immunoprecipitated from SDS extracts of cells or from 
laminarinase extracts of the cell walls of 7.5  x  107 plasmid-containing 
cells or 5  x  108 cells without plasmid as described previously (Lu et al., 
1994).  For immunoprecipitating secreted a-agglutinin, concentrated and 
dialyzed media were adjusted to 1% Triton X-100, 0.1% SDS, 50 mM Tris- 
HCI (pH 7.4), 150 mM NaCI, 5 mM EDTA, 1 mM PMSF, 30 ~g/ml each 
of leupeptin, pepstatin, and antipain. To 800 #1 of the material 5 ~1 anti- 
c~-agglutinln antiserum (AG3) was added. The antiserum was pre-adsorbed 
with heat-killed a cells as described (Wojciechowicz  and Lipke, 1989). The 
a-agglutinin immunopreeipitates were analyzed on 6%  SDS-polyacryl- 
amide gels, which were processed for fluorography (Lu et al., 1994) or im- 
munoblotting. For fluorography, the gels were soaked in sodium salicylate, 
dried, and exposed to Kodak X-omat XAR film at  -70°C for 2 d.  The 
a-agglutinln from a constant number of ceils was loaded in each lane, except 
for Fig. 2, in which a constant amount of radioactivity was loaded. 
Treatment with Endo N-Acetylglucosaminidase H 
After immunoprecipitation, ceagglutinin was eluted from protein A beads 
with 0.1 M sodium acetate, pH 5.5, 3% 2-mercaptoethanol, and 0.4% SDS 
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endo H buffer (20 mM sodium acetate, pH 5.5, 2 mM EDTA, 1 mM PMSE 
and 30 ttg/mi each of leupeptin, pepstatin, and antipain) to 100 #1.8 td of 
recombinant  endo  N-aeetylglucosaminidase  H  (endo  H;  Boehringer- 
Mannheim  Biochemieals,  Indianapolis,  IN) (8 mU) was added and the mix- 
ture was incubated overnight at 35"C. 
Immunoblotting 
After separation on SDS-polyacrylamide gels, proteins were transferred to 
nitrocellulose membranes overnight at 40 V. The membranes were blocked 
with 3 % gelatin at 30°C for 2 h, and incubated with the purified anti-~,6- 
glucan antibodies (0.5  ttg//zl) (1:2,500  dilution in PBS containing 0.1% 
Tweeu-20)  for 1 h at room temperature.  The blots were then incubated in 
peroxidase-conjngated  anti-rabbit lgG (Sigma  Chemical Co.,  St.  Louis, 
MO) 0:2,500 dilution in PBS containing 0.2%  Tween 20) for 45 rain at 
room temperature.  The immuuoblots were visualized  with ECL Western 
blotting detection reagents  (Amersham Corp., Arlington Heights,  IL) ac- 
cording to the manufacturer's instruction. For antibody competition experi- 
ments, pustulan (BI,6-glucan),  laminarin (B1,3-gluean), or mannan with a 
concentration of 1 mM glucose or mannose equivalent  was added to the 
anti-BI,6-glucan solution.  The pustelan, laminarin, and mannan were dis- 
solved in PBS by autoclaving  at ll0°C for 30 rain. 
Results 
The Molecular Size of  ~-Agglutinin Increases during 
Covalent Association with the Cell Wall 
We have previously identified three forms of ot-agglutinin 
with molecular sizes >300 kDa: two SDS-soluble forms and 
a cell wall form. The SDS extracts contain a GPI-anchored 
form and a form that has lost the fatty acid and inositol moie- 
ties from the anchor. These forms are predicted to be inter- 
mediates in the cell wall anchorage process (Lu et al., 1994). 
Cell wall ot-agglutinin was isolated from SDS-extracted 
cell walls by treatment with laminarinase,  which contains 
/31,3-glucanase  as the predominant activity (Fig. 1 A, lane/) 
(Van Rinsum et al.,  1991; Lu et al.,  1994). Laminarinase- 
mediated proteolysis of ~-agglutinin is not detectable under 
the experimental conditions (Lu et al., 1994). The >300-kD 
intermediate forms as well as a 140-kD intracellular form of 
a-agglutinin were immunoprecipitated from the SDS extract 
of the cells (Fig.  1 B, lane/). The apparent molecular sizes 
of the cell wall form and the SDS-soluble forms have not 
been determined previously; all three forms migrated near 
the  top  of 6%  SDS-polyacrylamide gels.  However, after 
treatment with  endo H,  which removes N-linked saccha- 
rides, the large forms that are extracted with SDS were re- 
duced to about 200 kD (Fig.  1 B, lane 2), whereas the endo 
H-treated  cell  wall  form  showed  a  molecular  weight  of 
240-300 kD (Fig. I A, lane 2). The apparent higher molecu- 
lar size of the cell wall form compared with the intermediate 
forms after endo H treatment, indicates that further modi- 
fication occurs in the process of covalent cell wall associ- 
ation. 
mnn9 cells make mannoproteins without outer mannose 
polysaccharide chains added to the N-linked core saccha- 
rides (Tsai et ai., 1984; Tanner and Lehle, 1987). In an mnn9 
mutant, an increase in molecular size of the cell wall form 
of  ~x-agglutinin relative to precursors was seen even in the ab- 
sence of endo H treatment (Fig.  1). The SDS extract of the 
mnn9 cells contained forms of ot-agglutinin  with molecular 
weights of 140 and 225 kD (Fig.  1 B, lane 3).  The size of 
the 140-kD form, which occurs in the ER (Lu et al., 1994), 
was not affected by the mnn9 mutation. In accordance with 
Figure 1. Molecular size of the cell wall, plasma membrane-bound, 
and  periplasrnic forms  of ot-agglutinin. W303-1B[pAGcxl'] cells 
(WE) and LB2134-2B (mnn9) cells were labeled with [35S]methi- 
onine and broken in SDS lysis buffer, a-Agglutinin was immuno- 
precipitated  from the  SDS  extracts  of the  cells  and  from  the 
laminarinase extracts of the cell walls using anti-a-agglutinin  an- 
tiserum, and analyzed by SDS-polyacrylamide gel electrophoresis 
and fluorography, (A) Laminarinase-extracted cell wall form of 
ot-agglutinin. (B)  SDS-extracted forms of ot-agglutinin (biosyn- 
thetic intermediates; Lu et al.,  1994). The >300-kD a-agglutinin 
contains a soluble >300 form and a membrane-bound >300-kD 
form (Lu et al., 1994). The molecular size standards on the right 
are labeled in kD. 
the mnn9 phenotype, the molecular size of the 225-kD form 
from mnn9 cells was close to that of the de-N-glycosylated 
soluble large forms of ot-agglutinin  (200 kD). The cell wall 
form of t~-agglutinin  from mnn9 cells,  although migrating 
faster than the cell wall form from wild type cells, had appar- 
ent molecular size of>250 kD (Fig. 1 A, lane 3). The appar- 
ent higher molecular size of the cell wall form (>250 kD) 
compared to the  SDS-extractable 225-kD  o~-agglutinin  in 
mnn9 cells again indicated that the a-agglutinin was mod- 
ified before or during anchorage in the cell wall. 
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Molecular Size of Cell Wall ~-Agglutinin 
Some/31,3-glucanase-extractable cell wall proteins are cova- 
lently linked to/$1,6-glucans (Montijn et al., 1994). We spec- 
ulated that the cell wall anchorage of ot-agglutinin resulted 
from a covalent linkage to the wall fll,6-glucan which was in 
turn cross-linked to other cell wall components. Therefore, 
krel,  kreS, kre6,  kre9,  and krell  gene disruption mutants, 
which have defects in synthesis of/~l,6-glucan, were tested 
for effects on ot-agglutinin. 
Assays for functional cell surface o~-agglutinin revealed no 
significant decrease in the agglutinability of the krel::HIS3 
and kre11::URA3 mutants relative to the isogenic wild-type 
strain (Table I). This result indicated that ot-agglutinin is ex- 
pressed on the cell surface of krel::HIS3  and krell::URA3 
mutants. Since the kre5::HIS3  and kret: :HIS3 mutant cells 
are abnormally large and the kre9::HIS3  cells formed ag- 
gregates, the agglutinability of these two mutants was difficult 
to  quantify using our assay,  which measures the  optical 
density of the cell suspension after the aggregates are sedi- 
mented (Terrance and Lipke, 1981). However, when kre6:: 
HIS3 or kre9::HIS3  mutant cells were mixed with tester a 
cells, larger aggregates were formed, indicating that these 
mutant cells are agglutinable. 
We next tested the  effect of KRE gene disruptions on 
ot-agglutinin  secretion. Wild type strain SEY6210  secreted 
a  small  amount  of  ot-agglutinin  into  the  medium.  The 
secreted o~-agglutinin had molecular size >300 kD, which 
was reduced to 200 kD after endo H  treatment (data not 
shown). The kre mutants secreted more ct-agglutinin into the 
growth medium than the wild-type strain. The fraction of the 
secreted ot-agglutinin to the laminarinase-extracted cell wall 
ct-agglutinin  increased two- to threefold in the krel::HIS3, 
kre6: :HIS3, kreg: :HIS3, and kre11:  :  URA3 mutants (Table I). 
kre5 mutants show a severe deficiency in B1,6-glucan syn- 
Table 1.  Effect  of kre Gene Disruptions  on Cell Surface 
Expression  and Secretion  of ot-Agglutinin 
Fraction of ct-agglutinin 
Genotype  AI*  secreted into medium¢ 
KRE  0.70  .07 
kre  I ::HIS3  0.68  .21 
kre5::HIS3  ND  .82 
kre6::HIS3  ND  .15 
kre9::HIS3  ND  .20 
krell::URA3  0.64  .13 
* AI, agglutination index. Higher AI indicates  a greater degree of agglutina- 
tion. The agglutination assay was performed as described previously (Terrance 
and Lipke, 1991). The tester a cells (X2180-1A)  were pretreated with a-factor 
as described (Terrance and Lipke,  1981).  ND, not determined. 
~; The kre mutants and their isogenic wild type swain (KRE) were metaboli- 
cally labeled with [35S]methionine for 30 min and separated from the media. 
The cell wall ct-agglutinin was solubilized from SDS-extracted  cell walls by 
treatment with laminarinase, and subsequently immunoprecipitated. Under the 
experimental conditions, half of the total amount of the cell wall a-agglntinin 
was extracted from the mutant and the wild type cell walls, as determined by 
time courses of release of a-agglutinin. The secreted a-agglutinin was im- 
munoprecipitated from the labeling media. The a-agglntinin precipitates  were 
subjected to SDS-polyacrylamide gel dectrophorresis followed by fluorogra- 
phy. ot-Agglntinin  bands were excised from the gel and quantitated by liquid 
scintillation  counting. The fraction of secreted o¢-agglutinin was defined as the 
radioactivity  of ct-agglutinin in the culture medium divided by the sum of the 
ot-agglutinin  radioactivity  in the medium and that extracted from cell walls. 
Cell wall a-agglutinin radioactivity was corrected for the efficiency of extrac- 
tion from the cell wall. 
thesis, a growth defect, and aberrant morphology (Meaden 
et al., 1990).  Two kre5::HIS3  MATer strains were obtained 
by  sporulation  of a  heterozygous diploid.  These  strains 
secreted the majority of their ot-agglutinln into the growth 
medium (Table I). Analysis of the cell walls showed <10% 
of wild type levels  of ot-agglutinin  in the walls (data not 
shown). Thus, the severe defect in glucan synthesis in the 
kre5::HIS3  strains was accompanied by a failure to anchor 
most of the ot-agglutinin  into the ceil wall. 
The ot-agglutinin secreted from the kre mutants exhibited 
no mobility difference from that secreted from the wild type 
cells (data not shown). Despite the increased secretion, a 
substantial amount of  a-agglutinin in kre mutants (other than 
kre5::HIS3)  remained associated  with the  cell  wall,  and 
could only be released by laminarinase treatment, suggesting 
that the majority of the ot-agglutinln produced in the krel:: 
HIS3, kre6".  :HIS3, kre9::HIS&  and krell:: URA3 mutants is 
anchored in the cell wall. 
The increase in ct-agglutinin  secretion could be a general 
effect of kre mutations on cell wall structure. A krel mutant 
oversecretes proteins normally found in the growth medium 
(Bussey et al., 1983), and analysis of the proteins in the cul- 
ture supernatant from wild type and krel cells showed in- 
creased levels of at least seven other proteins in the krel null 
mutant compared to the wild type strain (data not shown). 
To  determine  whether  anchorage  of ot-agglutinin  was 
specifically affected  by the kre mutations, we assayed the mo- 
lecular size of the ot-aggutinin from the cell walls of the mu- 
tants. Before endo H treatment, the laminarinase-extracted 
cell wall form of t~-agglutinin from the mutants and from the 
wild type strain migrated on the top of 6% SDS-polyacryl- 
am/de gels, and the molecular sizes could not be compared. 
After endo H  treatment,  the cell wall  ot-agglutinln  from 
krel::HIS3  and kre9::HIS3  mutants showed molecular sizes 
of 200-240  and  200-270  kD,  respectively,  significantly 
smaller than that from the isogenic wild type strain (Fig. 2 
A). A slight size reduction of the cell wall ot-agglutinin was 
observed in kre6::HIS3 and krell::URA3 mutants (Fig. 2 A). 
This reduction was observed in several preparations of cell 
wall ot-agglutinin  from these mutants. A  small amount of 
endo H resistant material was seen in extracts from all kre 
mutants. It is not clear whether this material represents an 
endo H-resistant form of ct-agglutinin  or non-glycosylated 
proteins that remain associated with ot-agglutinin during im- 
munoprecipitation. 
The altered cell wall structure of the krel mutant is likely 
to make the cell wall glucans more accessible to added en- 
zymes; therefore the reduced molecular size of the cell wall 
a-agglutinin from the krel: :HIS3 mutant could have resulted 
from more extensive digestion by laminarinase during the 
extraction from the cell wall (Boone et ai., 1990). To address 
this possibility, time courses of laminarinase digestion were 
performed.  Cell walls from krel::HIS3  cells were treated 
with laminarinase for various periods of time from 1-16 h. 
The extracted cell wall ot-agglutinin, after endo H treatment, 
showed no mobility difference over the time course (Fig. 2 
B). We also monitored laminafina~ digestion of ct-agglutinln 
isolated from wild type cells. The cell wall ct-agglutinln was 
solubilized from the wild type cell wall in an initial 2-h incu- 
bation, and then was reincubated in the presence of laminar- 
inase to examine whether extended laminarinase digestion 
would further reduce the size of the wild type cell wall 
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t~-agglutinin of  the same molecular size as that originally iso- 
lated (Fig. 2 B). These results imply that the lower molecular 
size of the cell wall a-agglutinin in the krel::HIS3 mutant rel- 
ative to  wild  type is  not  due  to  incomplete laminarinase 
digestion during the extraction from the wall of wild type 
cells. 
The molecular sizes of the non-cell wall intermediates of 
ot-agglutinin were unaffected by kre disruptions.  The SDS- 
extracted >300-kD ot-agglutinln from the wild type and mu- 
tant strains had an apparent molecular size of 200 kD after 
endo H  treatment (Fig.  2  C).  To further test whether the 
krel::HIS3  mutation  affects  only  cell  wall  proteins,  the 
plasma membrane-bound GPI-anchored glycoprotein Gaslp 
or Ggplp was immunoprecipitated from the membrane frac- 
tions (Nuoffer et al.,  1991; Vai et al.,  1990; Fankhauser and 
Conzelmann,  1991).  Gaslp from the krel mutant and from 
the wild-type strain exhibited no mobility difference (data 
not shown).  Therefore the krel::HIS3 mutation altered pro- 
cessing  of cell  wall-associated  c~-agglutinin,  but  did  not 
affect processing of a  membrane-associated GPI-anchored 
glycoprotein. 
Cell Wall a-Agglutinin Is Immunoreactive 
with Anti-Bl,6-Glucan Antibodies 
The possibility that the cell wall c~-agglutinin  was covalently 
linked to cell wall/~-glucan was further tested using specific 
anti-/~l,6-glucan  antibodies.  The  antibodies  were  raised 
against/31,6-glucan serum albumin conjugate (Montijn et al., 
1994) and purified using a/~l,6-glucan affinity column. Cell 
wall  a-agglutinin was immunoprecipitated from the  lami- 
narinase extract of the cell wall with anti-c~-agglutinin anti- 
bodies, and the precipitate was analyzed by immunoblotting 
with  anti-/3'l,6-glucan  antibodies.  The  cell  wall  form  of 
ct-agglutinin was recognized by the anti-/5'l,6-glucan antibod- 
ies both before and after treatment with endo H  (Fig.  3 B, 
lanes 1 and 2). This recognition was competitively inhibited 
by pustulan (~l,6-glucan) (Fig. 3 C, lanes 1 and 2), but not 
by  laminarin  (/~l,3-glucan)  or  mannan  (data  not  shown). 
These  results  indicate  that  the  epitope  on  the  cell  wall 
ot-agglutinin consists of ~l,6-glucan.  Cell wall ct-agglutinin 
from the krel::HIS3 cells was less reactive with the anti-15'l,6- 
glucan antibodies than that from the isogenic wild type strain 
(Fig. 4), consistent with a reduced size of/~l,6-glucan in the 
mutant. 
To determine whether the non-cell wall forms of t~-agglu- 
tinin  contained  /$1,6-glucan,  the  soluble  precursors  were 
precipitated from the  SDS  extract of wild type cells with 
anti-c~-aggutinin, and immunoblotted with anti-~,6-glucan 
antibodies. The 140 kD and the >300-kD forms, as well as 
their corresponding endo H-treated forms, did not react with 
the ffl,6-glucan antibodies (Fig. 3 B, lanes 3 and 4), whereas 
they were strongly stained when reprobed with the a-agglu- 
tinin  antibodies  (Fig.  3  A,  lanes  3  and  4).  A  weak,  im- 
munoreactive band migrated on the very top of the gel (Fig. 
3 B, lane 3).  However, this band is non-specific, because it 
was not competed by 131,6-glucan (Fig. 3 C, lane 3), did not 
comigrate with  the  >300-kD  ot-agglutinin band,  and  was 
also  seen  in  an  a  cell  extract  which  does  not  contain 
a-agglutinin  (data  not  shown).  Because  the  SDS  extracts 
contain two >300-kD forms of ot-agglutinin, the cells were 
Figure 2. Effect of KRE gene disruptions on the molecular size of 
t~-agglutinin, kre mutants and their isogenic wild type strain were 
labelled  with  [3SS]methionine, lysed,  and  cell  walls  were  sedi- 
mented and treated with laminarinase. (A) Laminarinase-extracted 
cell  wall form of c~-agglutinin. The cell walls were treated with 
laminarinase  for 4 h. c~-Agglutinin was immunoprecipitated  from 
the  laminarinase  extracts  of the  cell  walls. (B)  Time course  of 
laminarinase digestion. The cell wall from the krel cells was treated 
with laminarinase  for the indicated time.  The cell wall from the 
wild type cells (KRE) was digested with laminarinase for 2 h. The 
solubilized wall proteins from each strain were separated from the 
undigested cell wall (time 0 h), and incubated in the presence of 
laminarinase  for various periods  of time at 35°C. The cell wall 
ct-agglutinin was immunoprecipitated and treated with endo H. (C) 
SDS-extracted  intermediate  forms  of c~-agglutinin, c~-agglutinin 
was immunoprecipitated  from SDS extracts of kre and wild type 
cells, ct-Agglutinin precipitates were analyzed by SDS-polyacryl- 
amide gel electrophoresis followed by fluorography. Equal amounts 
of  radioactivity (cpm) were applied to each lane in each gel. Molec- 
ular size standards on the right are indicated in kD, and >300- and 
140-kD intermediate forms of ct-agglutinin are marked on the left. 
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W303-1B[pAGod'] ceils were lysed in SDS lysis buffer. The wall 
c~-agglutinin and the intermediate forms were immunoprecipitated 
with anti-ct-agglutinin antibodies from the laminarinase extracts of 
the cell walls and the SDS extracts of  cells, respectively.  The COOH- 
terminal truncated form of a-agglutinin (Aga1621p) was immuno- 
precipitated from the growth medium of an agctl::LEU2[pAGctl~t~ 
strain.  (A)  t~-Agglutinin probed  with  anti-u-agglutinin.  (B) 
t~-Agglutinin blot probed with anti-/31,6-glucan. (C) As in B, ex- 
cept that pustulan (/31,6-glucan, 1 mM glucose equivalent) was in- 
cluded in the anti-/31,6-glucan antibody solution. Equal amounts of 
a-agglutinin precipitate were loaded in the corresponding lanes in 
A, B, and C. 
lysed and fractionated into membrane and soluble protein 
fractions by ultracentrifugation, which separates the soluble 
periplasmic  >300-kD  form  from  the  plasma membrane- 
bound >300-kD form (Lu et al.,  1994).  Neither >300-kD 
form  was  reactive  with  the  anti-/31,6-glucan  (data  not 
shown).  These  results  indicate  that  the  addition  of/31,6- 
glucan occurs at the cell surface after formation of the solu- 
ble >300-kD form of c~-agglutinin. 
A truncation of the COOH-terminal 29-arnino acid resi- 
dues from Agedp (Agod62~p) eliminates cell surface attach- 
Figure 4. Effect of krel gene disruption on immunoreaetivity of the 
cell wall ct-agglutinin with anti-/~l,6-glucan. The kre/mutant and 
its isogenic wild-type strain (KRE) were lysed in SDS lysis buffer, 
and the cell walls were collected and treated with laminarinase. The 
wall c~-agglutinin  was immunoprecipitated with anti-t~-agglutinin, 
separated on SDS-polyacrylamide  gels, and blotted onto nitrocel- 
lulose membranes.  The blots were probed with anti-ct-agglutinin 
(A) or anti-/31,6-glucan (B). Equal amounts of samples were loaded 
in the corresponding lanes in A and B. 
ment and  allows  secretion  of active ot-agglutinin  into  the 
medium (Wojciechowicz et al.,  1993). The loss of cell sur- 
face attachment in the Agot162~p apparently results from a 
defect in GPI anchor addition (Wojciechowicz et al.,  1993). 
We therefore determined whether the AC_md~l gene product 
was  modified  by  addition  of/31,6-glucan.  Agct162tp  was 
precipitated with anti-ct-agglutinin from the growth medium 
of an agt~l::LEU2[pAGcd62tq  strain.  Agot162~p exhibited a 
mobility  similar  to  that  of the  SDS-extracted  >300-kD 
c~-agglutinin  from wild-type ceils (Fig. 3 A, lane 5).  After 
endo H  treatment,  the  size of the Ag~162tp shifted to 200 
kD  (Fig.  3  A,  lane  6).  Aga1621p did  not  react  with  the 
anti-/31,6-glucan,  either  before or  after endo  H  treatment 
(Fig.  3  B,  lanes 5  and  6).  A  very weak, /31,6-glucan  non- 
competitive signal was seen at the top of the gel (Fig.  3, B 
and C, lane 5).  This signal was non-specific, as it was also 
found in the growth medium of agal::LEU2  cells without 
pAGed6z~' (data  not  shown).  This  result  suggests that  the 
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oL-agglutinin and the/~l,6-glucan. 
Discussion 
Three extracellular forms of ot-agglutinin  have been iden- 
tiffed: a GPI-anchored form bound to the plasma membrane, 
a soluble periplasmic form which has lost the fatty acid and 
inositol from the GPI anchor, and the mature form that is 
covalenfly bound to the cell wall (Lu et ai., 1994). We have 
proposed that the plasma membrane form is released to pro- 
duce the periplasmic form, which then becomes linked to the 
cell wall. To examine the mechanism of cell wall attachment, 
we have further characterized these forms, which were pre- 
viously indistinguishable in SDS gel analysis due to their 
large size (>300 kD).  After endo H  treatment to release 
N-linked carbohydrate, the cell wall form had a higher mo- 
lecular size than the plasma membrane-bound and periplas- 
mic forms. In mnn9 cells, which are defective in addition of 
outer chain N-linked carbohydrate, a similar molecular size 
difference was detected even in the absence of endo H treat- 
ment. This size difference indicates that covalent modifica- 
tion of ot-agglutinln occurs either immediately before or dur- 
ing cell wall attachment. 
Two approaches demonstrated that a-agglutinin is cova- 
lenfly modified by addition of/S1,6 glucan in the process of 
cell  wall  anchorage.  /s1,6-glucan-specific  antibodies  spe- 
cifically reacted with cell wall tx-agglutinin but not with the 
plasma  membrane or periplasmic  forms of tx-agglutinin. 
ot-agglutinin  was also characterized in kre mutants, which 
are altered in/s1,6-glucan structure and/or levels in the cell 
wall. Mutations in krel and kre9 affect late steps in synthesis 
of cell wall/S1,6 glucan, and show a reduced size and altered 
structure (Boone et al., 1990; Brown and Bussey,  1993). In 
these mutants, cell wall a-agglutinin had markedly reduced 
size after endo H treatment (200-240 and 200-270 kD for 
krel and kre9, respectively, versus 240-300 kD for the wild- 
type). Cell wall ct-agglutinln from krel cells was less reactive 
with anti-B1,6-glucan antibodies in comparison to the wild- 
type, consistent with the shorter/s1,6-glucan polymers found 
in krel mutants. 
In addition to the alterations in/s1,6-glucan structure dis- 
cussed above, krel, kre5, kre6, kre9, and krell mutants show 
reduced amounts of cell  wall /s1,6-glucan  (Brown et al., 
1993). The tested kre mutants showed increased secretion of 
ct-agglutinin with a concomitant reduction in the fraction of 
c~-agglutinin bound to the cell wall. The increase in secretion 
of tx-agglutinin was most marked in the strain with the most 
severe phenotype. 
Covalent association of tx-agglutinin with/s1,6-glucan would 
provide a mechanism to anchor the glycoprotein to the cell 
wall matrix. The bonds created during the association of 
ct-agglutinin  or other mannoproteins with cell wall glucan 
are not known, but the structures of the components suggest 
several  possibilities. Ghican could be attached to tx-agglu- 
tinin through N- or O-linkage or through linkage to the GPI 
anchor. 
Several lines of evidence argue against N- or O-linkage of 
the glucan to the peptide. Endo H-treated cell wall tx-agglu- 
tinln remained reactive with the anti-BI,6-glucan antibodies; 
therefore the/s1,6-glucan is not attached to endo H-sensitive 
N-linked chains. Anchorage of tx-agglutinin and bulk man- 
noproteins is not affected in a rann9 mutant, which has se- 
verely truncated mannosyl side chains, or by tunicamycin 
treatment (Wojciechowicz  et ai.,  1993; Lu et al.,  1994). In 
addition, the a-agglutinin anchorage subunit Agaip contains 
no consensus N-glycosylation sites and appears to contain 
only O-linked carbohydrate mannosyl chains  (Lipke and 
Kurjan,  1992);  therefore unless a-  and c~-agglutinins use 
different  mechanisms of  cell wall attachment, linkage cannot 
be through a conventional N-linked carbohydrate chain. At- 
tachment through O-linked carbohydrate is not consistent 
with the alkali resistance of the/s-glucan association with 
mannoprotein (Van Rinsum et al.,  1991). 
Recently, Schreiner et al.  (1994)  have reported a direct 
linkage of/s-glucose to asparagine in mammalian laminin. 
A similar linkage in tx-agglutinin would be resistant to endo 
H and to tunicamycin, and S  ° cannot be ruled out. However, 
it is not apparent how formation of such a linkage would be 
dependent on GPI anchor addition in c~-agglutinin. 
The current results are consistent with/s1,6-glucan attach- 
ment to a modified GPI anchor. A COOH-terminal trunca- 
tion of ot-agglutinln that eliminates GPI anchor attachment 
results in secretion of tx-agglutinln  into the medium (Woj- 
ciechowicz et al.,  1993) and a lack of recognition by anti- 
/51,6-glucan antibodies (Fig. 3 A). The periplasmic form of 
ot-agghitinin lacks the inositol and fatty acid components of 
the GPI anchor but preliminary results indicate that at least 
the ethanolamine moiety of the GPI anchor remains (Lu, 
C. E, and P. N. Lipke, unpublished results). Removal of the 
phosphatidylinositol component of the GPI anchor would 
leave the COOH-terminal glycan attached to the protein, in- 
cluding ethanolamine phosphate and at least one carbohy- 
drate residue (De Nobel and Lipke, 1994). The reducing end 
of  the GPI-derived glycan would remain with the protein and 
could become attached to cell wall/s1,6-glucan by a trans- 
glycosylation reaction (De Nobel  and Lipke,  1994).  The 
structure of Candida albicans mannoproteins is consistent 
with this hypothesis;/s1,6-glucan linkage to marmoproteins 
is through a phosphodiester linkage (Kapteyn et al., 1994), 
as is the linkage between GPI anchors and proteins. Further 
support for this hypothesis comes from construction of chi- 
meric proteins (Van Berkel et al.,  1994).  Addition of the 
COOH-terminal 30-amino acid residues of c~-agglutinin to 
the secreted marker protein ct-galactosidase is sufficient to 
/s-glucosylate and anchor the tx-galactosidase in the cell wall 
of S. cerevisiae. This 30-residue ct-agglutinin sequence con- 
talns the GPI addition signal, but only a few potential O-gly- 
cosylation sites,  and no Asn residues. 
Processing and assembly of ct-agglutinin  and/s1,6-glucan 
are complex processes. The cellular locations of  the products 
of KRE and related genes imply that/$1,6  glucan assembly 
is initiated in the ER and proceeds during transport through 
the secretory pathway (Brown et al.,  1993).  Krelp appears 
to be a GPI anchored extracellular protein; therefore final as- 
sembly of the glucan may be extracellular, ot-Agghitinin is 
also synthesized in the ER and altered by GPI addition and 
• N- and O-glycosylation in the secretory pathway (Lu et al., 
1994). A GPI-anchored form of tx-agglutinin of >300 kD is 
membrane associated and extracellular (Lu et al.,  1994). 
Neither this GPI-anchored ot-agglutinin  form nor the peri- 
plasmic form reacted with anti-BI,6-glucan antibodies and 
neither form showed size alterations in kre mutants (Figs. 1 
and 2). Therefore these forms were not modified by glucan 
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cell wall  form.  We propose that  the periplasmic  form of 
c~-agglutinin,  and possibly other cell wall mannoproteins,  is 
cross-linked  to preformed  #l,6-glycan,  perhaps  by  trans- 
glycosylation of the GPI anchor-derived glycan, and then be- 
comes integrated  into the growing cell wall by linkage of 
/31,6-glucan  to  ~l,3-glucan  polymers.  The  data  we  have 
presented suggests that the cross-linking  reactions are ex- 
tracellular,  and occur within the periplasmic space and cell 
wall. 
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